Michael Terrence Gibbs
CIK: 0001665000
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
Michael Terrence Gibbs files insider reports with the SEC as General Counsel of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by Michael Terrence Gibbs since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Gibbs Michael Terrence
Gibbs Michael Terrence (SEC CIK 0001665000) files insider reports with the SEC as General Counsel of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Gibbs Michael Terrence, a Form 4, filed on Jan 2, 2025. Those filings report 2 transactions, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Gibbs Michael Terrence's filings is in LEXINGTON, MA.
Recent filings by Gibbs Michael Terrence
- Nov 4, 2024: Grants or awards of TTOO derivative securities (2 lines, Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Saunders Ninfa, Director
- Toft Robin, Director